TXG Stock Up 27% after 5-Day Win Streak
10x Genomics (TXG) stock hit day 5 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 27% return. The company has gained about $482 Mil in value over the last 5 days, with its current market capitalization at about $1.8 Bil. The stock remains 1.9% above its value at the end of 2024. This compares with year-to-date returns of 8.6% for the S&P 500.
Comparing TXG Stock Returns With The S&P 500
The following table summarizes the return for TXG stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | TXG | S&P 500 |
|---|---|---|
| 1D | 3.8% | 0.0% |
| 5D (Current Streak) | 26.9% | 1.3% |
| 1M (21D) | 25.1% | 4.1% |
| 3M (63D) | 76.4% | 15.6% |
| YTD 2025 | 1.9% | 8.6% |
| 2024 | -74.3% | 23.3% |
| 2023 | 53.6% | 24.2% |
| 2022 | -75.5% | -19.4% |
Gains and Losses Streaks: S&P 500 Constituents
There are currently 42 S&P constituents with 3 days or more of consecutive gains and 69 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 9 | 47 |
| 4D | 12 | 20 |
| 5D | 10 | 1 |
| 6D | 7 | 1 |
| 7D or more | 4 | 0 |
| Total >=3 D | 42 | 69 |
Key Financials for 10x Genomics (TXG)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $618.7 Mil | $610.8 Mil |
| Operating Income | $-204.3 Mil | $-194.6 Mil |
| Net Income | $-255.1 Mil | $-182.6 Mil |
Last 2 Fiscal Quarters:
| Metric | 2024 FQ4 | 2025 FQ1 |
|---|---|---|
| Revenues | $165.0 Mil | $154.9 Mil |
| Operating Income | $-49.8 Mil | $-48.5 Mil |
| Net Income | $-49.0 Mil | $-34.4 Mil |
While TXG stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming the S&P 500 over the last 4-year period. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.